For the past few years, a rising quantity of scholars has taken notice of the correlation between metabolic disorders and thyroid hormone sensitivity indexes which have been proven to be credible predictors of IR, T2D, hyperuricemia, cardiometabolic risk, and disturbances of lipid metabolism [11–14]. The gene discussed is TG; the disease is metabolic disease.